ArticleMedical oncology (Northwood, London, England)2022

Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia.

Buket Ozel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.